Vyteris, Inc. (NASDAQ: VHYN)
-- A spinout of the Transdermal Systems unit of Becton Dickinson & Company (BD). Vyteris’ transdermal
technology delivers drugs using low-level electrical energy and is the first active drug delivery patch to receive market
approval from the U.S. FDA. The Company is based in Fair Lawn, NJ.